50 years with lithium treatment in affective disorders: Present problems and priorities

World Journal of Biological Psychiatry

Volumn 2, Issue 1, 2001, Pages 18-26

  Vestergaard, Per ^a   Licht, Rasmus W ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

bipolar disorder; compliance; efficacy; lithium

Indexed keywords

LITHIUM CARBONATE;

BIPOLAR DISORDER; BRAIN; CHEMICALLY INDUCED DISORDER; COGNITIVE DEFECT; DOSE RESPONSE; DRUG MONITORING; HISTORY; HYPOTHYROIDISM; METABOLISM; MOOD DISORDER; PATIENT COMPLIANCE; PSORIASIS; REVIEW; SOMATOFORM DISORDER;

BIPOLAR DISORDER; BRAIN; COGNITION DISORDERS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG MONITORING; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HYPOTHYROIDISM; LITHIUM CARBONATE; MOOD DISORDERS; PATIENT COMPLIANCE; PSORIASIS; SOMATOFORM DISORDERS;

EID: 0035241503     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.3109/15622970109039980     Document Type: Review

References (57)

1. Aagaard J, Vestergaard P (1990) Predictors of outcome in prophylactic lithium treatment: a 2-year prospective study. J Affect Disord 18:259-266.
2. Ahlfors UC, Baastrup PC, Dencker SJ, Elgen K, Lingjaerde O, Pedersen V, Schou M, Aaskoven O (1981) Flupenthixol decanoate in recurrent manic-depressive illness. Acta Psychiatr Scand 64:226-237.
3. Albrecht C (1997) Unerwünschte Wirkungen der Lithiumtherapie an der Haut. In: Müller-Oerlinghausen B, Greil W, Berghöfer A, eds. Die Lithiumtherapie. Springer, Berlin, pp 392-401.
4. Altshuler LL, Post RM, Leverich GS, Mikalaukas K, Rosoff A, Ackerman L (1995) Antidepressant-induced mania and cycle acceleration: a controversy revisited. Am J Psychiatry 1 52:1130-1138.
5. Baptista T, Teneud L, Contreras Q, Alastre T, Burguera JL, Burguera M, Baptista E, Weiss S, Hernandez L (1995) Lithium and body weight gain. Pharmacopsychiatr 28:35-44.
6. Bauer M, Döpfmer S (1999) Lithium augmentation in treatmentresistant depression: Meta-analysis of placebo-controlled studies. J Clin Psychopharmacol 19:427-434.
7. Bendz H, Aurell M, Balldin J, Mathé AA, Sjödin IN (1994) Kidney damage in long-term lithium patients: A cross-sectional study of patients with 15 years or more on lithium. Nephrol Dial Transplant 9:1250-1254.
8. Berghofer A, Schestag M, Greil W (1997) Neurologische Indikationen von Lithium. In: Muller-Oerlinghausen B, Greil W, Berghofer A (eds) Die Lithiumtherapie. Springer, Berlin, pp 309-315.
9. Bowden CL (1996) Role of newer medications for bipolar disorder. J Clin Psychopharmacology 16(Suppl 1):48S-55S.
10. Bowden CL, Calabrese JR, McElroy SL, Gyulai L, Wassef A, Petty F, Harrison GP, Chou C-Y, Keck PE, Rhodes LJ, Swann AC, Hirschfeld MA, Wozniak PJ (2000) A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Arch Gen Psychiatry 57:481-489.
11. Brodersen A, Licht RW, Vestergaard P, Olesen AV, Mortensen PB (2000) Sixteen-year mortality in patients with affective disorder commenced on lithium. Br J Psychiatry 1 76:429-433.
12. Bschor T, Bauer M, Albrecht J (1997) Beeinflussung der Schilddrusenfunktion durch Lithium. In: Muller-Oerlinghausen B, Greil W, Berghofer A (eds) Die Lithiumtherapie. Springer, Berlin, pp 357-367.
13. Burrows GD, Tiller JW (1999) Cade's observation of the antimanic effect of lithium and early Australian research. Aust NZ J Psychiatry 33: S27-S31.
14. Cade JFJ (1949) Lithium salts in the treatment of psychotic excitement. Med J Aust 2:349-352.
15. Chaudron LH, Jefferson JW (2000) Mood stabilizers during breastfeeding: a review. J Clin Psychiatry 61:79-90.
16. Delva NJ, Letemendia FJJ (1982) Lithium treatment in schizophrenia and schizoaffective disorders. Br J Psychiatry 141:387-400.
17. Ewald H (In Press) Genetics of Bipolar Disorder. In: Marneros A, Angst J (eds) Bipolar Disorders - 100 years after Kraepelin. Amsterdam, Kluwer Academic Publishers.
18. Gelenberg AJ, Jefferson JW (1995) Lithium tremor, J Clin Psychiatry 56:283-287.
19. Gelenberg AJ, Kane JM, Keller MB, Lavori P, Rosenbaum JF, Cole K, Lavelle J (1989) Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder. N Engl J Med 321:1489-1493.
20. Goodwin GM (1994) Recurrence of mania after lithium withdrawal. Implications for the use of lithium in the treatment of bipolar affective disorder. Br J Psychiatry 164:149-152.
21. Goodwin F, Jamison KR (1990) Manic-depressive illness. Oxford University Press, New York.
22. Greil W, Ludwig-Mayerhofer W, Erazo N, Schöchlin C, Schmidt S, Engel RR, Czernik A, Giedke H, Müller-Oerlinghausen B, Osterheider M, Rudolf GAE, Sauer H, Tegeler J, Wetterling T (1997) Lithium versus carbamazepine in the maintenance treatment of bipolar disorders - a randomised study. J Affective Disord 43:151-161.
23. Guscott R, Taylor L (1994) Lithium prophylaxis in recurrent affective illness. Efficacy, effectiveness and efficiency. Br J Psychiatry 164:741-746.
24. Harrow M, Goldberg JF, Grossman LS, Meltzer HY (1990) Outcome in manic disorders. Arch Gen Psychiatry 47:665-671.
25. Johnson FN (1984) The history of lithium therapy. Macmillan Press, London.
26. Johnston AM, Eagles JM (1999) Lithium-associated clinical hypothyroidism. Br J Psychiatry 1 75:336-339.
27. Kallner G, Lindelius R, Petterson U, Stockman O, Thorn A (2000) Mortality in 497 patients with affective disorders attending a lithium clinic or after having left it. Pharmacopsychiat 33:8-13.
28. Kaschka WP (1997) Die Lithiumintoxikation. In: Muller-Oerlinghausen B, Greil W, Berghofer A (eds) Die Lithiumtherapie. Springer, Berlin, pp 424-434.
29. Kleiner J, Altshuler L, Hendrick V, Hershman JM (1999) Lithiuminduced subclinic hypothyroidism: review of the literature and guidelines for treatment. J Clin Psychiatry 60:249-255.
30. Lehmann K (1997) Pharmakokinetik von Lithiumsalzen. In: Müller-Oerlinghausen B, Greil W, Berghöfer A (eds) Die Lithiumtherapie. Springer, Berlin, pp 148-160.
31. Licht RW (1998) Drug treatment of mania: a critical review. Acta Psychiatr Scand 97:387-397.
32. Licht RW (2000) Typical and atypical antipsychotics in bipolar disorder. Acta Neuropsychiatr 12:115-119.
33. Licht RW, Gouliaev G, Vestergaard P, Dybbro J, Lund H, Merinder L (1994a) Treatment of manic episodes in Scandinavia: the use of neuroleptic drugs in a clinical routine setting. J Affective Disord 32:179-185.
34. Licht RW, Larsen JO, Smith D, Brændgaard H (1994b) Effect of chronic lithium treatment with or without haloperidol on number and sizes of neurons in rat neocortex. Psychopharmacol 115:371-374.
35. Licht RW, Vestergaard P, Rasmussen N-A, Jepsen K, Brodersen A, Hansen PEB (2000) 2-year outcome in bipolar disorder patients beginning prophylactic lithium. Acta Neuropsychiatr 12:162.
36. Licht RW, Bysted M, Christensen M (In Press) Fixed dose risperidone in mania - an open experimental trial. Int Clin Psychopharmacol.
37. Llewellyn A, Stowe ZN, Strader JR (1998) The use of lithium and management of women with bipolar disorder during pregnancy and lactation. J Clin Psychiatry 59(Suppl 6):57-64.
38. Maarbjerg K, Vestergaard P, Schou M (1987) Changes in serum thyroxine (T4) and serum thyroid stimulating hormone (TSH) during prolonged lithium treatment. Acta Psychiatr Scand 75:217-221.
39. Maj M, Pirozzi R, Kemali D (1989) Long-term outcome of lithium prophylaxis in patients initially classified as complete responders. Psychopharmacology 98:535-538.
40. Maj M, Pirozzi R, Magliano L, Bartoli L (1998) Long-term outcome of lithium prophylaxis in bipolar disorder, a 5-year prospective study of 402 patients at a lithium clinic. Am J Psychiatry 155:30-35.
41. Manji HK, McNamara R, Chen G, Lenox RH (1999) Signalling pathways in the brain: Cellular transduction of mood stabilisation in the treatment of manic-depressive illness. Aust NZ J Psychiatry 33: S65-S83.
42. Mitchell PB (1999) The place of anticonvulsants and other putative mood stabilisers in the treatment of bipolar disorder. Aust NZ J Psychiatry 33: S99-S107.
43. Müller-Oerlinghausen B (1997) Unerwüinschte Wechselwirkungen von Lithiumsalzen mit anderen Arzneimitteln. In: Müller-Oerlinghausen B, Greil W, Berghöfer A (eds) Die Lithiumtherapie. Springer, Berlin, pp 446-455.
44. Nilsson A (1993) The anti-aggressive actions of lithium. Rev Contemp Pharmacother 4:269-285.
45. Nilsson A (1995) Mortality in recurrent mood disorders during periods on and off lithium. A complete population study in 362 patients. Pharmacopsychiat 28:8-13.
46. Nolen WA, Kupka RW (2000) The efficacy of valproate, lamotrigine and gabapentin in bipolar disorder; review of double-blind controlled studies. Acta Neuropsychiatr 12:122-127.
47. O'Connell RA, Mayo, JA, Flatow L, Cuthbertson B, O'Brian BE (1991) Outcome of bipolar disorder on long-term treatment with lithium. Br J Psychiatry 159:123-129.
48. Schou M (1984) Long-lasting neurological sequelae after lithium intoxication. Acta Psychiatr Scand 70:594-602.
49. Schou M, Vestergaard P (1988) Prospective studies on a lithium cohort. 2. Renal function. Water and electrolyte metabolism. Acta Psychiatr Scand 78:427-433.
50. Silverstone T, McPherson H, Hunt N, Romans S (1998) How effective is lithium in the prevention of relapse in bipolar disorder? A prospective naturalistic follow-up study. Aust N Zealand J Psychiatry 32:61-66.
51. Stokes PE, Kocsis JH, Orestes JA (1976) Relationship of lithium chloride dose to treatment response in acute mania. Arch Gen Psychiatry 33:1080-1084.
52. Thomsen K, Schou M (1999) Avoidance of lithium intoxication: Advice based on knowledge about the renal lithium clearance under various circumstances. Pharmacopsychiatr 32:83-86.
53. Tohen M, Waternaux CM, Tsuang MT (1990) Outcome in mania. Arch Gen Psychiatry 47:1106-1111.
54. Vestergaard P (1994) Compliance bei Langzeitmedikation mit Lithium: Ein Hauptfaktor erfolgreicher Prophylaxe bei manischdepressiver Erkrankung. In: Müller-Oerlinghausen B, Berghöfer A (eds) Ziele und Ergebnisse der medikamentösen Prophylaxe affektiver Psychosen. Georg Thieme Verlag, Stuttgart, pp 9-12.
55. Vestergaard P, Poulstrup IN, Schou M (1988) Prospective studies on a lithium cohort. 3. Tremor, weight gain, diarrhoea, psychological complaints. Acta Psychiatr Scand 78:434-441.
56. Vestergaard P, Licht RW, Brodersen A, Rasmussen N-A, Christensen H, Arngrim T, Granvall B, Kristensen E, Poulstrup I (1998) Outcome of lithium prophylaxis: a prospective follow-up of affective disorder patients assigned to high and low serum lithium levels. Acta Psychiatr Scand 98:310-315.
57. Winokur G, Coryell W, Akiskal HS, Endicott J, Keller M, Mueller T (1994) Manic-depressive (bipolar) disorder: the course in light of a prospective ten-year follow-up of 131 patients. Acta Psychiatr Scand 89:102-110.